In the present study, pinocembrin was demonstrated to decrease memory impairment, neurological scores, neuronal loss in the hippocampus and the number of GFAP-positive cells in the hippocampal CA1 region of TGCI rats. This evidence concerns the gene GFAP and memory impairment.